loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

198 Reports in Biotechnology

Cell-based Assays: Technologies and Global Markets

Published - Dec 2018 | Analyst - Sathya Durga| Code - BIO080D

The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.

High Content Screening/Imaging: Technologies and Global Markets

Published - Nov 2018 | Analyst - Anuj Pathak| Code - BIO166A

The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.

Bioinformatics: Technologies and Global Markets

Published - Nov 2018 | Analyst - Vijay Laxmi| Code - BIO051D

The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.

Proteomics: Technologies and Global Markets

Published - Oct 2018 | Analyst - Bhavna Joshi| Code - BIO034E

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Protein Analysis: Subfocus on Oncoproteomics

Published - Oct 2018 | Analyst - Anuj Pathak| Code - BIO168A

The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.

Genetic Modification Therapies Clinical Applications: Gene Thera...

Published - Sep 2018 | Analyst - John Bergin| Code - BIO159A

The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Biomarkers: Technologies and Global Markets

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO061E

The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.

Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Global Markets for Enzymes in Industrial Applications

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO030K

The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Switching to CRISPR–Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Analyst - Todd Graham| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Analyst - Andrew McWilliams| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Analyst - Vijay Laxmi| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Analyst - BCC Research Staff| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Analyst - John Bergin| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Analyst - Paul Taylor| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Analyst - Todd Graham| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Analyst - Marianna Tcherpakov| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

The Chinese Market for DNA Sequencing

Published - Jun 2018 | Analyst - Jason Chen| Code - BIO152B

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Biosimilars: Global Markets

Published - Apr 2018 | Analyst - Kamna Jhamb| Code - BIO090C

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Artificial Blood: Global Markets to 2027

Published - Apr 2018 | Analyst - BCC Research Staff| Code - BIO164A

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Cell Therapy Processing: Global Markets and Technologies

Published - Apr 2018 | Analyst - Sangeeta Rai| Code - BIO160A

The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.

The Global Market for Stem Cells

Published - Apr 2018 | Analyst - Paul Evers| Code - BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

17 Upcoming Reports in Biotechnology

Chromatography in Pharmaceuticals and Biotechnology: Global Markets

Target Date - Nov 2018| Author - Kamna Jhamb| Code - BIO163A| Price - $5,500

Report Includes

  • An overview of the global market for chromatography in pharmaceuticals and biotechnology
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Identification of the segments that should experience high growth during the time frame covered
  • Information on competitor initiatives, and information pertaining to research and development status of chromatography in pharmaceuticals and biotechnology
  • Comprehensive profiles of major players in the industry

Notify Me

Diabetes Therapies and Innovations: Global Markets to 2023

Target Date - Dec 2018| Author - BCC Research Reference Staff| Code - BIO180A| Price - $5,500

Report Includes

  • An overview of the global market for diabetes therapies and innovations
  • Analyses of global market trends, with data from 2014-2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Characterization and quantification of the market by segment and by region
  • Coverage of historic and forecast data of the market
  • Description of market dynamics, including drivers and restraints
  • Discussion of key mergers and acquisitions in the market
  • Profiles of major companies in the industry

Notify Me

Cell Line and Membrane Market

Target Date - Dec 2018| Author - Sathya Durga| Code - BIO178A| Price - $5,500

Report Includes

  • Identification of applications of cell lines in drug development, diagnostics, and molecular biology
  • Description of advancements in cell lines for cancer-based therapies
  • Details of CAR-T Cell and immune check point inhibitor therapy
  • Comparative study of autologous vs allogenic cells manufacturing process
  • Explanation of increasing adoption of cell line technologies in cell-based assay and surging demand of antibody production as a driving force to the cell line market
  • Detailed profiles of the major vendors in the global cell line and membrane market

Notify Me

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

Target Date - Dec 2018| Author - Kamna Jhamb| Code - BIO170A| Price - $5,500

Report Includes

  • An overview of the global markets for bioprocess optimization and digital bio-manufacturing (DM)
  • Evaluation of role of process analytical technologies (PAT) in DM
  • A look into the new developments, new product launches and regulatory aspects in the global market
  • Discussion about critical issues impacting the adoption of DM in pharmaceuticals as well as emerging trends in DM technologies
  • Detailed analysis of industry 4.0 in DM
  • Comprehensive profiles of market players in the industry

Notify Me

Flow Cytometry: Products, Technologies and Global Markets

Target Date - Dec 2018| Author - Honey Dave| Code - BIO085D| Price - $5,500

Report Includes

  • An industry analysis of the products, technologies and applications of flow cytometry within the industry
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Segmentation of the global flow cytometry market by products and services, technology types, applications, end users and geographical regions
  • A look at the regulatory environment and growth driving factors that affect the global market
  • Separate chapter on number of U.S. patents and patent applications with emphasis on new developments
  • Detailed profiling of leading companies in flow cytometry industry

Notify Me

Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023

Target Date - Dec 2018| Author - Anuj Pathak| Code - BIO167A| Price - $5,500

Report Includes

  • An overview of the global markets and technologies for cell separation and characterization in solid tumor
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Overview of the main markers used for isolation, identification and purification for solid tumors, including surface cell-adhesion molecules such as CD133, CD24, hyaluronic acid (HA) receptor CD44, cytoprotective enzymes such as aldehyde dehydrogenase, ALDH, and transcription factors OCT-4, SOX-2.
  • Discussion of the various cell separation technique and technologies such as fluorescence-activated cell sorting (FACS), magnet-activated cell sorting (MACS), density gradient centrifugation, dielectrophoretic (DEP), aqueous two-phase system, field flow fractionation (FFF) and microfluidic platforms
  • Coverage of the major products of the industry such as solid tumor kits, multi-marker solid tumor panels, reagents and microchips and micro-beads
  • Comprehensive analysis of the major companies active in the market, including Merck, Miltenyi Biotec, Novartis, AstraZeneca, Abott Lab, Biogen Idec Inc, Bristol-Myers Squibb, Baxter, Johnson & Johnson and Sanofi

Notify Me

Biomarker Deals: Terms, Value and Trends, 2008-2018

Target Date - Dec 2018| Author - Marianna Tcherpakov| Code - BIO169A| Price - $5,500

Report Includes

  • An overview of the global trends, value and terms for biomarker deals
  • Definition and types of biomarkers deals and milestone payments and their value in different deals
  • Description of technologies for biomarkers, including PCR IHC and sequencing
  • Coverage of companies developing biomarkers/market participants and current R&D trends including academics
  • Detailed profiles of the major vendors in the market

Notify Me

Synthetic (Cultured) Meat: Technologies and Global Markets

Target Date - Dec 2018| Author - Vijay Laxmi| Code - BIO174A| Price - $5,500

Report Includes

  • Industry analysis of technologies and global markets for synthetic (cultured) meat
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on major drivers and regional dynamics of the global synthetic (cultured) meat market and current trends within the industry
  • A look at the government regulations that can affect the global synthetic (cultured) meat market
  • Discussion of the major players across each regional synthetic (cultured) meat market

Notify Me

Cancer Cell Analysis, Instruments, Consumables and Reagents

Target Date - Dec 2018| Author - Sathya Durga| Code - BIO177A| Price - $5,500

Report Includes

  • Detailed overview of the global market for cancer cell analysis in instruments, reagents and consumables
  • Analyses of the global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Qualitative and quantitative study of the cancer cell analysis industry by product type, end user, analyses technique, application
  • Assessment of the major drivers and regional dynamics of the global cancer cell analysis market and current trends within the industry
  • Emphasis on the vendor landscape and detailed profiles of the major vendors in the cancer cell analysis market

Notify Me

Validation, Calibration and Standardization in Life Sciences Market

Target Date - Dec 2018| Author - Sathya Durga| Code - BIO179A| Price - $5,500

Report Includes

  • Country specific data and analysis for US, Canada, Germany, France, UK, Spain, China, India, Japan, and Australia
  • Explanation of validation and calibration of instruments such as heap filters, pH meters, incubators, autoclaves, HPLC units, and GC units
  • Discussion of ongoing research in treatments of various diseases and susceptibility of various microbes towards traditional medicines as driving factors to the industry
  • Insight into the regulatory compliances in life science industry
  • Detailed profile of major companies of the industry

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM